How neuroinflammation contributes to neurodegeneration

Science. 2016 Aug 19;353(6301):777-83. doi: 10.1126/science.aag2590.

Abstract

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron's environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier / pathology
  • Blood-Brain Barrier / physiopathology
  • CX3C Chemokine Receptor 1
  • Humans
  • Inflammation / complications*
  • Inflammation / genetics
  • Inflammation / pathology
  • Membrane Glycoproteins / genetics
  • Microglia / pathology*
  • Microglia / physiology
  • Neurodegenerative Diseases / etiology*
  • Neurodegenerative Diseases / pathology*
  • Neurodegenerative Diseases / therapy
  • Neurons / pathology*
  • Neurons / physiology
  • Protein Aggregates
  • Receptors, Chemokine / genetics
  • Receptors, Immunologic / genetics

Substances

  • CX3C Chemokine Receptor 1
  • CX3CR1 protein, human
  • Membrane Glycoproteins
  • Protein Aggregates
  • Receptors, Chemokine
  • Receptors, Immunologic
  • TREM2 protein, human